High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
GLP-1 drugs like Ozempic, Mounjaro, Wegovy, and Zepbound are powerful tools for treating diabetes and aiding with weight ...
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The ...
The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
This week, a letter surfaced in which Eli Lilly asked for a patient to release medical information so it could contact her ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...